Index Entries - Covid Index

1147 Results

Title	IS Publication Date
Excess non-COVID-19 mortality in Norway 2020–2022	January 22, 2024
Excess Weight and COVID-19: Insights from new evidence	July 2020
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues	July 22, 2020
Expert testimony of Dr. Christina Parks, PhD	August 25, 2021
Experts and talking heads claim covid vaccines stop transmission compilation	October 17, 2021
Exploring inter-country coronavirus mortality	July 9, 2020
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach	March 25, 2021
Explosive: Embalmer reveals 93% of cases have deadly clots caused by the COVID vax	February 12, 2022
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant	November 2, 2021
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice	November 2, 2022
External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive results	November 30, 2020
Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trial	October 13, 2020
Facemask versus No Facemask in Preventing Viral Respiratory Infections During Hajj: A Cluster Randomised Open Label Trial	March 11, 2019
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers)	Revised December 22, 2022
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) — Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19)	Revised May 5, 2022
Fact Sheet for Recipients and Caregivers - Emergency Use Authorization (EUA) of the Pfizer-Biontech COVID-19 Vaccine to Prevent Coronavirus	Revised August 12, 2021
FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT THE PFIZERBIONTECH COVID-19 VACCINE AND THE PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) FOR USE IN INDIVIDUALS 6 MONTHS THROUGH 4	Revised December 8, 2022
FAQ about COVID-19	September 17, 2021
Fauci on Antibody Dependent Enhancement (ADE)	March 2020
FDA Briefing Document - Moderna COVID-19 Vaccine	December 17, 2020
FDA Briefing Document - Pfizer-BioNTech COVID-19 Vaccine	December 10, 2020
FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting	December 10, 2020
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine	December 11, 2020
FDA tweet on Ivermectin in August 2021	August 21, 2021
Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue	March 31, 2021
Federal Register, Vol. 85, No. 216	November 6, 2020
Fertility declines near the end of the COVID-19 pandemic: Evidence of the 2022 birth declines in Germany and Sweden	June 9, 2022
Fibrin drives thromboinflammation and neuropathology in COVID-19	August 28, 2024
Fighting Goliath: Exposing the flawed science and statistics behind the COVID-19 event	August 30, 2024
Final Report: Inquiry into the Appropriateness and Efficacy of the COVID-19 Response in Canada	November 28, 2023
First case of postmortem study in a patient vaccinated against SARS-CoV-2	April 16, 2021
Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines	January 3, 2024
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial	November 12, 2020
FMTVDM Quantitative Nuclear Imaging finds Three Treatments for SARS-CoV-2	February 8, 2021
Form S-1 Registration Statement Under the Securities Act of 1933: BioNTech SE	September 9, 2019
Form S-1 Registration Statement Under the Securities Act of 1933: Moderna, Inc.	November 9, 2018
Freedom of Information (FOI) request: COVID-19 deaths and autopsies Feb 2020 to Dec 2021	January 17, 2022
Frequency and Associations of Adverse Reactions of COVID19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States	February 3, 2022
From risk to resilience: An equity approach to COVID-19 - Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2020	October 2020
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity	February 14, 2016
Funeral Director Tells All	December 6, 2021
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis	August 26, 2020
Furor Erupts: Billions Going To Hospitals Based On Medicare Billings, Not COVID-19	April 10, 2020
Gibraltar cancels Christmas celebrations amid Covid spike	November 17, 2021
Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)	April 21, 2021
Global perspective of COVID-19 epidemiology for a full-cycle pandemic	October 7, 2020
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273	February 2, 2024
Graphene and graphene oxide as nanomaterials for medicine and biology application	June 7, 2018
Graphene and the Immune System: A Romance of Many Dimensions	June 13, 2017
Graves' Disease Following COVID-19 Vaccination	April 23, 2022

Page 9 of 23